ANNOUNCEMENT

MedCity CONVERGE brings together the entire ecosystem to discuss Healthcare Innovation this July.

Topic: Durham

Wow of the Week: First lab-grown blood vessel implanted in kidney dialysis patient

Wow of the Week: First lab-grown blood vessel implanted in kidney dialysis patient

June 8, 2013 8:00 am by | 0 Comments

A Duke University spinoff has reached a milestone in tissue engineering as it transplanted the first bioengineered blood vessel into the arm of a patient with end-stage kidney disease.In its ... Read more
Q is for Quintiles: CRO picked good time to return to the public markets

Q is for Quintiles: CRO picked good time to return to the public markets

May 9, 2013 9:00 am by | 0 Comments

[Update] Contract research organization Quintiles returned to the public markets today, trading on the NYSE under the stock symbol Q. It raised $947 million after it was priced at $40. ... Read more
Durham’s Tranzyme headed west after merger with California company

Durham’s Tranzyme headed west after merger with California company

April 25, 2013 3:59 am by | 0 Comments

DURHAM -- Tranzyme Pharma, a Durham-based biopharmaceutical company that discontinued clinical trials for two drug candidates last year, is planning to merge with private drug developer Ocera Therapeutics Inc. in ... Read more
Durham’s Chimerix could go public as early as next week

Durham’s Chimerix could go public as early as next week

April 3, 2013 4:00 am by | 0 Comments

Durham drug-development company Chimerix, which could go public as early as next week, is anticipating that Wall Street will value the business at more than $300 million.Chimerix filed a registration ... Read more
Jumps, skips & steps add up to medals & virtual high-fives with this activity tracking game for kids

Jumps, skips & steps add up to medals & virtual high-fives with this activity tracking game for kids

February 28, 2013 10:54 pm by | 0 Comments

Kids today are moving less and eating more to the point that one in three of them is overweight or obese, and technology – television, computers, video games, etc. – ... Read more
Personalized immunotherapy could signal first combination treatment for renal cell carcinoma patients

Personalized immunotherapy could signal first combination treatment for renal cell carcinoma patients

January 15, 2013 10:17 pm by | 0 Comments

It’s been a few months since Dendreon got slammed for providing inconsistent data analysis to U.S. regulators for Provenge, its therapeutic cellular immunotherapy for prostate cancer. As Argos Therapeutics recruits ... Read more
Durham startup developing stents for bifurcated lesions garners $24 million

Durham startup developing stents for bifurcated lesions garners $24 million

January 11, 2013 1:33 pm by | 0 Comments

Tryton Medical, a Durham, North Carolina, startup developing coronary stents to treat bifurcated lesions announced earlier this week that the company has had an initial closing of a $24 million ... Read more
$125M early stage fund seeks to invest in health startups in N.C. and southeastern U.S.

$125M early stage fund seeks to invest in health startups in N.C. and southeastern U.S.

January 7, 2013 9:49 am by | 2 Comments

Hatteras Venture Partners announced Monday that the company has closed its fourth fund totaling $125 million.The Durham, North Carolina-based venture capital firm invests in device, diagnostic, biopharma, health IT and ... Read more
Durham drug developer BioCryst to slash half its workforce

Durham drug developer BioCryst to slash half its workforce

December 7, 2012 9:52 pm by | 0 Comments

Durham drug developer BioCryst Pharmaceuticals said Friday it is cutting half its staff in the wake of a failed merger attempt and two suspensions of experimental drugs.BioCryst, with employees in ... Read more
Genomics field gets a boost with rare-cancer breakthrough by Chordoma Foundation

Genomics field gets a boost with rare-cancer breakthrough by Chordoma Foundation

October 15, 2012 2:53 pm by | 0 Comments

Today, scientists made a major step in cancer research; they identified the underlying genetic cause behind a rare form of carcinoma cancer, chordoma.This discovery puts the emerging field of genomics ... Read more
Experimental lupus therapy from Argos in partnering talks after strong phase 1

Experimental lupus therapy from Argos in partnering talks after strong phase 1

June 8, 2012 1:24 pm by | 1 Comments

 The experimental lupus treatment being developed by Argos Therapeutics is showing promise in early stage clinical trials, but the questions remain whether it’s enough progress to attract interest from a ... Read more
Surgical sealant firm HyperBranch raises $1.7M after getting CE Mark

Surgical sealant firm HyperBranch raises $1.7M after getting CE Mark

June 6, 2012 10:19 am by | 0 Comments

Wound and surgical sealant company HyperBranch Medical Technology, moving to commercialize a new sealant technology in Europe and secure regulatory clearance in the United States, has raised $1.7 million in ... Read more
Quintiles tops investigator recruiting survey but pharmas are ‘dissatisfied outsourcers’

Quintiles tops investigator recruiting survey but pharmas are ‘dissatisfied outsourcers’

June 5, 2012 12:45 pm by | 0 Comments

It’s no secret pharmaceutical companies are outsourcing more and more work to clinical research organizations. But when it comes to recruiting doctors to run the studies, they’re not happy at ... Read more
With hepatitis C compound in phase 2, Scynexis raises $11.5M of $15M target

With hepatitis C compound in phase 2, Scynexis raises $11.5M of $15M target

May 23, 2012 3:41 pm by | 0 Comments

Drug discovery and development company Scynexis, which is in midstage clinical development of a novel hepatitis C treatment, is getting closer to reaching its $15 million fundraising target.Scynexis has raised ... Read more
Quintiles report: Healthcare payers to get greater drug development role

Quintiles report: Healthcare payers to get greater drug development role

May 22, 2012 12:22 am by | 0 Comments

Pharmaceutical companies and insurers are still figuring out how they’ll work with each other, but a clear majority of both camps surveyed in Quintiles‘ annual New Health Report expect that ... Read more